Cardiovascular Disease Associated with NAFLD
December 15, 2011
NAFLD is the hepatic manifestation of metabolic syndrome, and is associated with cardiovascular risk. In patients with clinical indications for coronary angiogram, fatty liver is associated with coronary artery disease independently of other metabolic factors, stated researchers in a study published in Gut. However, fatty liver cannot predict cardiovascular mortality and morbidity in patients with established coronary artery disease.
Gut 2011: 60: 1721-27
0 out of 0 users found this page helpful.
Was this page helpful?
Only current members of the American Gastroenterological Association may post comments to this page.
Login To Comment
